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The State Council of the People’s Republic of China has officially assigned the 
Ministry of Commerce to be in charge of pharmaceutical business management in 
2009. Along with the continuous deepening of national medical system reform, the 
government has published series of policies concerning pharmaceutical distribution 
industry, such as the latest national GSP standards, national essential drug system and 
"Development plan of national pharmaceutical distribution industry” (2011-2015)" 
etc., intend to reshuffle the industry. The policies have focused on reducing enterprise 
quantity to increase industry concentration, changing the current status of many small 
but scattered distribution businesses to a more organized distribution structure. And 
the final objective is to improve distribution efficiency, strengthen competitiveness of 
key industry players, provide more convenience on purchasing safe medicine and 
satisfy the pharmaceutical distribution requirements of public health system. 
Under this environment, we have seen a big wave of merger and reorganization 
within the pharmaceutical distribution industry. The industry wholesale giants such as 
Sinopharm, China Resources Pharmaceutical Group, Shanghai Pharma, which has 
represented 28% of national pharmaceutical sales value in 2013, with 330 billion 
RMB in total, has launched rounds of merger and integration. Other regional 
pharmaceutical wholesale leaders have all speeded up their acquisitions. 
Do all the previous merger and acquisition cases all bring positive effect to 
enterprise development? Does any problem have been aroused in these enterprises 
afterwards? Are there any means to hand and avoid the problems? All sort of research 
on these questions will bring realistic meaning since most of the key pharmaceutical 
wholesalers are state-owned and most of the acquisition targets are private companies, 
the differences of company system, culture and operation concept will definitely 
cause issues in any steps of the integration process. 
The author has participated into a typical acquisition of private company by 
own-stated enterprise – Longweitongxin’s merger case. In this paper, the author 
makes a deep research on the enterprise strategy, management guideline, financial 
system, human resource and company culture of the integrated entity after analyzing 
all the problems in the process and summarizing from experience of handling them. 













before merger and all the preparation for the both sides; Secondly, the method of 
setting strategy planning group, building operation management committee, assigning 
full-time integration manager; Thirdly, invitation to the manager of acquisition to join 
the board; Fourthly, communication with minority stockholders and helping them to 
adapt to new working style afterwards, all the conclusions might help the integrated 
enterprise to run in efficient way after merger and acquisition in the future. 
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我国医药行业发展的最重要特征之一是政策答导性。2009 年 8 月，国务院











































全的商业分销网络：2009 年 8 月，国药控股湖北物流中心在武汉兴建；一个月
之后，国药控股长沙物流中心开始建设；12 月 16 日，国药控股山东公司成立；
据统计 2010 年、2011 年和 2012 年上半年，国药控股并购企业的数量分别为 21
家、35 家和 11 家；成长迅猛，公司的销售额在 2011 年突破 1000 亿，2013 年超














并而成的新上药集团，以上海为大本营，答要覆盖长三角。2010 年 1 月，“新
上药集团”宣布收购广州中山医药、山东商联和常州亚邦；2011 年通过整合中
信医药、北京科园等公司很快在我国经济最发达的华东、华北、华南三大区域为
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